IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meri, T.
Right arrow Articles by Zipfel, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meri, T.
Right arrow Articles by Zipfel, P. F.

 Previous Article  |  Next Article 

Infection and Immunity, November 2004, p. 6633-6641, Vol. 72, No. 11
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.11.6633-6641.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

The Hyphal and Yeast Forms of Candida albicans Bind the Complement Regulator C4b-Binding Protein

T. Meri,1,2 A. M. Blom,3 A. Hartmann,1 D. Lenk,1 S. Meri,2 and P. F. Zipfel1*

Hans Knöll Institute for Natural Products Research, Jena, Germany,1 Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland,2 Department of Clinical Chemistry, University Hospital Malmö, University of Lund, Malmö, Sweden3

Received 12 March 2004/ Returned for modification 3 May 2004/ Accepted 26 July 2004

Candida albicans, an important pathogenic yeast, activates all three pathways of the complement system. To understand how this yeast evades the effects of the activated system, we have analyzed the binding of the classical pathway inhibitor C4b-binding protein (C4BP) by C. albicans. Purified native as well as recombinant C4BP bound dose dependently to the yeast and hyphal forms, as shown by multiple methods, such as confocal microscopy, flow cytometry, a novel enzyme-linked immunosorbent assay, absorption from human serum, and direct binding assays with purified proteins. A prominent binding site was identified at the tip of the germ tube, a structure that is considered important for tissue penetration and pathogenesis. The binding site in C4BP was localized to the two N-terminal complement control protein domains by using recombinant deletion constructs and site-specific monoclonal antibodies. As the alternative pathway inhibitors factor H and FHL-1 also bind to C. albicans, the binding of all three plasma proteins was compared. Simultaneous binding of the classical regulator C4BP and the alternative pathway regulator factor H was demonstrated by confocal microscopy. In addition, FHL-1 competed for binding with C4BP, suggesting that these two related complement regulators bind to the same structures on the yeast surface. The surface-attached C4BP maintains its complement regulatory activities and inactivates C4b. The surface-attached human C4BP serves multiple functions relevant for immune evasion and likely pathogenicity. It inhibits complement activation at the yeast surface and, in addition, mediates adhesion of C. albicans to host endothelial cells.


* Corresponding author. Mailing address: Dept. of Infection Biology, Hans Knöll Institute for Natural Products Research, Beutenbergstrasse 11a, D-07745 Jena, Germany. Phone: 49 03641 656 900. Fax: 49 03641 656 902. E-mail: zipfel{at}pmail.hki-jena.de.

Editor: S. H. E. Kaufmann


Infection and Immunity, November 2004, p. 6633-6641, Vol. 72, No. 11
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.11.6633-6641.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2004 by the American Society for Microbiology. All rights reserved.